2ShimJC, Shin JG, Deanna L, et al. Adjunctive Treatment with a do- pamine partial agonist, aripiprazole, for antipsychotic-induced hy- perprolactinemia : A placebo-controlled trial [ J ]. Am J Psychiatry, 2007,164 : 1404. 被引量：1
3Kinon B J, Liu SH, Stauffer VL, et al. Bone loss associated with hy- perprolactinemia in patients with schizophrenia[ J]. Clinical Schiz- ophrenia Related Psychoses ,2013 : 1-27. 被引量：1
4Laekeman, G, Zwaenepoel, L, Reyntens, Jet al. Osteoporosis after combined use of a neuroleptic and antidepressants [ J ]. Pharmacy world and science, 2008, 30(5):613. 被引量：1
5Naidoo U, C-off DC, Klibanski A, et al. Hyperprolactinemia and bone mineral density: the potential impact of antipsychot-ic agents [ J An International Journal, 2003, 28(Suppl/2) : 97. 被引量：1
6Zhang JH,Seeman MV. Antipsyehotic drugs, menstrual reg- ularity and osteoporosis risk[J ]. Archives of women's mental health, 2002, 5(3):93. 被引量：1
7Besnard I, Auclair V, Callers" G, et al. Antipsychotic- drug -induced hyperprolactinemia: physiopathology, clinical fea- tures and guidance[J]. Encephale, 2014, 40(1): 86. 被引量：1
